It all started pleasantly enough.

Katten Muchin Rosenman announced it had hired partner Deepro Mukerjee and eventually four other patent attorneys from Alston & Bird in April. The firm told the New York Law Journal the new team was expected “to generate significant revenue for the firm in the pharmaceutical space.”